Showing results (1-10 of 63) with videos related to
Sort By:
Pageof 7
Annals of the New York Academy of Sciences|June 12, 1995
Studies on heterocycle-based pure estrogen antagonistsE Von Angerer, C Biberger, S LeichtlThe Journal of Steroid Biochemistry and Molecular Biology|May 1, 1994
1-Carbamoylalkyl-2-phenylindoles: relationship between side chain structure and estrogen antagonismE von Angerer, C Biberger, E Holler, et al.Archiv Der Pharmazie|October 30, 1998
2-Phenylbenzo[b]thiophene-based antiestrogens with mammary tumor inhibiting activityS Leichtl, E von AngererThe Journal of Steroid Biochemistry and Molecular Biology|April 1, 1996
2-Phenylindoles with sulfur containing side chains. Estrogen receptor affinity, antiestrogenic potency, and antitumor activityC Biberger, E von AngererThe Journal of Steroid Biochemistry and Molecular Biology|June 9, 1998
1-Benzyl-2-phenylindole- and 1,2-diphenylindole-based antiestrogens. Estimation of agonist and antagonist activities in transfection assaysC Biberger, E von AngererArchiv Der Pharmazie|October 20, 2000
Antiestrogenic activities of 3,8-dihydroxy-6,11-dihydrobenzo[a]carbazoles with sulfur-containing side chainsT Golob, C Biberger, G Walter, et al.Current Opinion in Drug Discovery & Development|August 4, 2009
Tubulin as a target for anticancer drugsE von AngererJournal of Medicinal Chemistry|November 1, 1982
Effect of N,N'-diethyl-1,2-bis(2,6-dichloro-4-hydroxyphenyl)ethylenediamines on the 7,12-dimethylbenz[a]anthracene-induced mammary carcinoma of the ratE von AngererJournal of Medicinal Chemistry|January 1, 1987
2-Phenylindoles. Effect of N-benzylation on estrogen receptor affinity, estrogenic properties, and mammary tumor inhibiting activityE von Angerer, J StrohmeierArchiv Der Pharmazie|September 1, 1990
2-phenylindole-linked nitroimidazoles as potential radiosensitizers for estrogen receptor positive tumorsS Erber, E von AngererPageof 7